Clinical trial
IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff
NCT00177970 · University of Pittsburgh, Other · Terminated
Key facts
| NCT number | NCT00177970 |
|---|---|
| Title | IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff |
| Official title | Intravenous Immunoglobulin G Versus Placebo for the Treatment of Patients With Severe Clostridium Difficile-Associated Diarrhea and Colitis |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | Shadyside Hospital Foundation Bayer Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Clostridium Difficile-associated Diarrhea (CDAD) |
| Intervention type | Drug |
| Interventions | intravenous immunoglobulin G (IVIG), Placebo |
| Enrollment | 14 |
| Start date | Oct 1, 2003 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | Oct 25, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: